
Journal of Medicinal Chemistry p. 518 - 525 (1992)
Update date:2022-08-02
Topics:
Bouzard, D.
Cesare, P. Di
Essiz, M.
Jacquet, J. P.
Ledoussal, B.
et al.
A series of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids have been prepared and tested for their in vitro and in vivo antibacterial activities.The 5-methyl group gave better in vitro activity with the 1-cyclopropyl appendage, but poorer activity with the 1-tert-butyl moiety.With the 1-(2,4-difluorophenyl) substitution, the influence of the 7-cycloalkylamino group was determinant: a (3S)-3-aminopyrrolidine was shown to enhance greatly the in vitro and in vivo activity of the 5-methyl derivative.Compound 33 (BMY 43748) was selec ted as a promising candidate for an improved therapeutic agent.
View MoreContact:732.938.2777
Address:5012 Industrial Road Farmingdale, NJ 07727
Jining tiansheng chemical co.,ltd.
Contact:+86-537-5158722
Address:ROOM 1011, BLOCK B, CUIDU INTERNATIOAL BUSINESS CENTER, JINING CITY, CHINA
HANGZHOU PANYU CHEMICAL CO.,LIMITED
Contact:+86-571-86578491
Address:Rm 605, NO.1870 Binsheng Road,Binjiang Dist, Hangzhou, China
Zhejiang Kangfeng Chemical Co.,LTD.
Contact:+86-579-86709687
Address:Xueshizhai Industrial Zone, Weishan Town,Dongyang City, Zhejiang Province ,China
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Doi:10.1016/S0040-4039(00)97324-6
(1990)Doi:10.1007/BF00957863
(1990)Doi:10.1039/jr9320002488
(1932)Doi:10.1021/om2004964
(2011)Doi:10.1134/S1070328416040011
()Doi:10.1021/ja00262a026
(1986)